Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 98927
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.98927
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.98927
Ref. | Selection | Comparability | Outcome | Total score | |||||
Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Demonstration that outcome of interest was not present at start of study | Comparability of cohorts on the basis of the design or analysis | Assessment of outcome | Was follow-up long enough | Adequacy of follow up of cohorts | ||
Zhao et al[20] | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 8 | |
Ikuta et al[19] | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 |
Bai et al[24] | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 |
Muhammad et al[25] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Qu et al[21] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
- Citation: Xu M, Zhou SR, Li YL, Zhang CH, Liao DZ, Wang XL. Efficacy of sorafenib combined with transarterial chemoembolization in the treatment of advanced hepatocellular carcinoma: A meta-analysis. World J Gastrointest Oncol 2025; 17(2): 98927
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/98927.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.98927